1 - 15 of 35 Results Clear All
The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
New class of resistance-proof drugs could one day transform treatments for viral diseases
News Release Research (Publication) Center for Cell Circuitry Virology Weinberger Lab Chaturvedi
The APQC Blog—Gladstone President Deepak Srivastava, MD, President Emeritus Robert Mahley, MD, PhD, Senior Investigators Melanie Ott, MD, PhD, and Katie Pollard, PhD, explain how they and others at Gladstone create a collaborative research culture and plan to balance safety with the chance encounters that fuel creativity.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Huang Lab Ott Lab Pollard Lab Srivastava Lab Weinberger Lab
Gladstone discoveries compete head-to-head with other scientific advancements
Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab Chaturvedi
abc7 NEWS—Senior Investigator Leor Weinberger, PhD, and Research Investigator Sonali Chaturvedi, PhD, explain their work on a therapy that sharply reduces viral load in the nose of hamsters after a single administration and could add a promising new tool to the therapeutic arsenal against COVID-19.
Gladstone Experts COVID-19 Virology Weinberger Lab
San Francisco Business Times—Senior Investigator Leor Weinberger, PhD, pioneered a new class of antivirals called therapeutic interfering particles (TIPs), which were recently shown to be effective against SARS-CoV-2 in animal models. The approach is now being developed by a startup company and will be headed to clinical trials.
Gladstone Experts COVID-19 Center for Cell Circuitry Virology Weinberger Lab
Gladstone scientists develop a single-dose intranasal treatment that is effective against variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Virology Weinberger Lab Chaturvedi
Researchers at Gladstone Institutes focus on innovative strategies that could finally allow people living with HIV to stop taking daily medications
Gladstone Experts HIV/AIDS Virology Greene Lab Ott Lab Roan Lab Weinberger Lab
The awards will support high-risk, high-reward research into a fundamentally new type of antiviral and a molecular strategy to fight cancer
Grants News Release COVID-19 Ramani Lab Weinberger Lab
Gladstone researchers discover a fundamental mechanism that appears to speed the change of stem cells into other cell types
News Release Research (Publication) Virology Weinberger Lab Stem Cells/iPSCs Chaturvedi
Three Gladstone research associates describe their work and why they love working at Gladstone
Research Associates Committee Profile McDevitt Lab Weinberger Lab
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts HIV/AIDS Center for Cell Circuitry Virology Weinberger Lab
Varying levels of proteins in cytomegalovirus particles help the virus survive in different conditions.
News Release Research (Publication) Flow Cytometry Core Virology Weinberger Lab Basic Science Chaturvedi
Leor Weinberger is selected by the National Institute on Drug Abuse for his innovative HIV research
Awards HIV/AIDS Weinberger Lab
Gustavo Vasen selected as a 2020 Pew Latin American Fellow in the Biomedical Sciences
Awards Weinberger Lab
